Shanghai Xunhe Pharmaceutical Technology Co. Ltd.

Chine

 
Quantité totale PI 12
Rang # Quantité totale PI 126 552
Note d'activité PI 1,8/5.0    11
Rang # Activité PI 80 747

Brevets

Marques

3 0
1 0
8 0
0
 
Dernier brevet 2024 - Sulfoximide substituted indazole...
Premier brevet 2017 - 2,4-disubstituted pyrimidine der...

Derniers inventions, produits et services

2023 Invention Sulfoximide substituted indazole irak4 kinase inhibitor, preparation method thereof and use there...
Invention Use of pyridinyl sulfonamide phosphate compound in preparing anti-cerebral edema drug. Use of a p...
2022 Invention Sulfoximide substituted indazole irak4 kinase inhibitor, preparation method therefor, and use the...
Invention Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereof. The presen...
2021 Invention Torsemide phosphate prodrug, preparation method and composition thereof. The present application...
2020 Invention Pyridine sulfonamide phosphate compound, preparation method therefor and application thereof. The...
Invention Torsemide sodium monohydrate, crystal form thereof and composition thereof. The present invention...
Invention Torasemide phosphate prodrug, preparation method therefor and composition having same. The presen...
2019 Invention Dihydro-pyrrolo-pyrimidine selective jak2 inhibitor. The present invention relates to the technic...
2017 Invention 2,4-disubstituted pyrimidine derivative as cdk inhibitor and use thereof. The present invention r...
Invention Heterocyclic-substituted pyridinopyrimidinone derivative as cdk inhibitor and use thereof. The pr...